Green Cross Corporation (142280) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Green Cross Corporation (142280:KRX), powered by AI.

Current Price
₩6,230
P/E Ratio
37.1
Market Cap
135.9B
Sector
Healthcare
What is the Green Cross Corporation stock price forecast?

Green Cross Corporation is currently trading at ₩6,230. View real-time AI analysis on Alpha Lenz.

What is Green Cross Corporation insider trading activity?

View the latest insider trading data for Green Cross Corporation on Alpha Lenz.

What is Green Cross Corporation's P/E ratio?

Green Cross Corporation's P/E ratio is 37.1.

Green Cross Corporation

KRX · 142280
₩6,230+1,370(+28.19%)Market closedKRX regular session 09:00–15:30 KST
Ask about Green Cross Corporation's future dividend policy...
Alpha Chat Insight

Green Cross Corporation trades at a P/E of 37.1 (premium valuation) with solid ROE of 8.6%.

Ask for details

Company Overview

Green Cross Corporation is a globally recognized biopharmaceutical company dedicated to the development, manufacturing, and distribution of various healthcare products. Primarily focusing on vaccines and plasma-derived therapies, Green Cross plays a crucial role in advancing public health standards. The company's innovative approach in biopharma research and development aids in addressing unmet medical needs, particularly in the areas of immunology, hematology, and rare diseases. Green Cross Corporation's impactful presence is observed within the healthcare and pharmaceutical sectors, where it contributes significantly to therapeutic advancements and healthcare solutions. With a robust pipeline of products, the corporation is instrumental in mitigating disease impact through cutting-edge biotechnological applications. Further establishing its significance, Green Cross operates with a commitment to sustainable practices, aligning with global health initiatives and environmental stewardship. Through strategic partnerships and a focus on genetic engineering, Green Cross continues to foster medical advancements and plays a vital role in enhancing global health outcomes.

CEO김연근
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees122

Company Statistics

FY 2025

Profile

₩135,914,477,440Market Cap
₩108,413,453,290Revenue
21.82MShares Out
122Employees

Margins

13.98%Gross
6.24%EBITDA
2.66%Operating
1.90%Pre-Tax
3.19%Net

Valuation

37.07P/E
3.06P/B
1.25EV/Sales
22.92EV/EBITDA
59.19P/FCF

Growth (CAGR)

-1.40%Rev 3Yr
-0.89%Rev 5Yr
N/AOp Inc 3Yr
-7.22%Op Inc 5Yr
N/ANet Inc 3Yr
-13.60%Net Inc 5Yr

Returns

3.88%ROA
8.57%ROE
5.37%ROIC

Financial Health

₩372,632,440Cash & Cash Equivalents
₩43,771,914,270Net Debt
95.21%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Green Cross Corporation (ticker: 142280) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 122 employees. Market cap is $135.9B.

The current price is ₩6,230 with a P/E ratio of 37.07x and P/B of 3.06x.

ROE is 8.57% and operating margin is 2.66%. Annual revenue is $108.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Green Cross Corporation (142280) Stock Forecast 2026 ₩6,230 — Price, Financials & Analyst Targets | Alpha Lenz